解决布普伦诺芬供应障碍:一个指导意见评论
Journal of the American Pharmacists Association : JAPhA
|January 25, 2024
概括
美国毒品执法局 (DEA) 的指导信可以改善对阿片类药物使用障碍 (MOUD) 的关键药物布普伦诺芬的获取. 这可以澄清分销规则,缓解药店的担忧,提高MOUD的可用性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 公共卫生政策 公共卫生政策
- 监管事务 监管事务
背景情况:
- 由于供应方面的限制,目前药房中的布普伦诺芬可用性受到限制.
- 联邦法规和阿片类药物诉讼限制了药品的分销和发行.
- 现有的解决方案还没有充分改善对阿片类药物使用障碍 (MOUD) 药物的获取.
研究的目的:
- 提出一种新的解决方案,以克服布普伦诺啡因供应方面的限制.
- 探索美国毒品执法局 (DEA) 指导信在改善MOUD访问方面的潜力.
- 为了解决有关责任和DEA对布普伦诺芬分销的审查的担忧.
主要方法:
- 对现有的DEA指导信机制的分析.
- 关于针对布普伦诺非因分销的特定DEA指导信的建议.
- 审查法律先例和监管解释.
主要成果:
- 禁毒局的指导信提供了一个直接的沟通道,以提高监管的清晰度.
- 一封有针对性的指导信可以缓解批发商和药店对加强审查的担忧.
- 建议对布普伦诺芬相对于"高度转移"物质的地位进行澄清.
结论:
- 药监局的指导信可以是一个可行的策略,以减少布普伦诺啡的供应侧限制.
- 这种指导可以为分销商和药房提供保证,鼓励增加MOUD的可用性.
- 这种方法支持更广泛的目标,即提高对阿片类药物使用障碍的药物获取.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
733
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
733
Drug Abuse and Addiction: Pharmacological Phenomena
476
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
476
Opioid Analgesics: Synthetic and Semisynthetic Opioids
300
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
300
Drug Control Governance: Regulatory Bodies and Their Impact
160
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
160
Drug Delivery: Parenteral Route
532
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
532
Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44


